Effects of phytosterols on markers of inflammation: A systematic review and meta-analysis

Atherosclerosis

Volumn 248, Issue , 2016, Pages 76-83

  Rocha, Viviane Z ^a   Ras, Rouyanne T ^b   Gagliardi, Ana C ^a   Mangili, Leonardo C ^a   Trautwein, Elke A ^b   Santos, Raul D ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

Atherosclerosis; C reactive protein; Cholesterol; Inflammation; Phytosterols; Plant sterols; Stanols

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOSTEROL; TRIACYLGLYCEROL; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; CHOLESTEROL; LIPID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; BLOOD; CHEMISTRY; INFLAMMATION; METABOLISM; PLANT; REGRESSION ANALYSIS;

ANTI-INFLAMMATORY AGENTS; BIOMARKERS; CHOLESTEROL; CHOLESTEROL, LDL; HUMANS; INFLAMMATION; LIPIDS; PHYTOSTEROLS; PLANTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; TRIGLYCERIDES;

EID: 84960439402     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.01.035     Document Type: Article

References (49)

1. Baigent C., Blackwell L., Emberson J., Holland L.E., Reith C., et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010 Nov 13, 376(9753):1670-1681. Cholesterol Treatment Trialists C, PubMed PMID: 21067804. Pubmed Central PMCID: 2988224.
2. Katan M.B., Grundy S.M., Jones P., Law M., Miettinen T., Paoletti R., et al. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin. Proc. 2003 Aug, 78(8):965-978. PubMed PMID: 12911045.
3. Demonty I., Ras R.T., van der Knaap H.C., Duchateau G.S., Meijer L., Zock P.L., et al. Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. J. Nutr. 2009 Feb, 139(2):271-284. PubMed PMID: 19091798.
4. Ras R.T., Geleijnse J.M., Trautwein E.A. LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies. Br. J. Nutr. 2014 Jul, 112(2):214-219. PubMed PMID: 24780090. Pubmed Central PMCID: 4071994.
5. Cannon C.P., Blazing M.A., Giugliano R.P., McCagg A., White J.A., Theroux P., et al. Ezetimibe added to statin therapy after acute coronary syndromes. N. Engl. J. Med. 2015 Jun 18, 372(25):2387-2397. PubMed PMID: 26039521.
6. Gylling H., Plat J., Turley S., Ginsberg H.N., Ellegard L., Jessup W., et al. Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease. Atherosclerosis 2014 Feb, 232(2):346-360. PubMed PMID: 24468148.
7. Sudhop T., von Bergmann K. Sitosterolemia-a rare disease. Are elevated plant sterols an additional risk factor?. Z. fur Kardiologie 2004 Dec, 93(12):921-928. PubMed PMID: 15599566.
8. Hansel B., Carrie A., Brun-Druc N., Leclert G., Chantepie S., Coiffard A.S., et al. Premature atherosclerosis is not systematic in phytosterolemic patients: severe hypercholesterolemia as a confounding factor in five subjects. Atherosclerosis 2014 May, 234(1):162-168. PubMed PMID: 24657386.
9. Ras R.T., Hiemstra H., Lin Y., Vermeer M.A., Duchateau G.S., Trautwein E.A. Consumption of plant sterol-enriched foods and effects on plasma plant sterol concentrations-a meta-analysis of randomized controlled studies. Atherosclerosis 2013 Oct, 230(2):336-346. PubMed PMID: 24075766.
10. Ras R.T., Fuchs D., Koppenol W.P., Garczarek U., Greyling A., Keicher C., et al. The effect of a low-fat spread with added plant sterols on vascular function markers: results of the investigating vascular function effects of plant sterols (INVEST) study. Am. J. Clin. Nutr. 2015 Apr, 101(4):733-741. PubMed PMID: 25809853. Pubmed Central PMCID: 4381780.
11. Othman R.A., Moghadasian M.H. Beyond cholesterol-lowering effects of plant sterols: clinical and experimental evidence of anti-inflammatory properties. Nutr. Rev. 2011 Jul, 69(7):371-382. PubMed PMID: 21729090.
12. Tsimikas S., Willerson J.T., Ridker P.M. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J. Am. Coll. Cardiol. 2006 Apr 18, 47(8 Suppl. l):C19-C31. PubMed PMID: 16631506.
13. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. Jan. 9;375(9709):132-140. PubMed PMID: 20031199. eng.
14. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., et al. C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med. 2005 Jan 6, 352(1):20-28. PubMed PMID: 15635109.
15. Ridker P.M., Luscher T.F. Anti-inflammatory therapies for cardiovascular disease. Eur. Heart J. 2014 Jul 14, 35(27):1782-1791. PubMed PMID: 24864079. Pubmed Central PMCID: 4155455.
16. Athyros V.G., Kakafika A.I., Papageorgiou A.A., Tziomalos K., Peletidou A., Vosikis C., et al. Effect of a plant stanol ester-containing spread, placebo spread, or mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors. Nutrition, metabolism, and cardiovascular diseases. NMCD 2011 Mar, 21(3):213-221. PubMed PMID: 19939653.
17. Devaraj S., Autret B.C., Jialal I. Reduced-calorie orange juice beverage with plant sterols lowers C-reactive protein concentrations and improves the lipid profile in human volunteers. Am. J. Clin. Nutr. 2006 Oct, 84(4):756-761. PubMed PMID: 17023701.
18. Micallef M.A., Garg M.L. Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis 2009 Jun, 204(2):476-482. PubMed PMID: 18977480.
19. Cater N.B., Garcia-Garcia A.B., Vega G.L., Grundy S.M. Responsiveness of plasma lipids and lipoproteins to plant stanol esters. Am. J. Cardiol. 2005 Jul 4, 96(1A):23D-28D. PubMed PMID: 15992512.
20. De Jong A., Plat J., Bast A., Godschalk R.W., Basu S., Mensink R.P. Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients on current statin treatment. Eur. J. Clin. Nutr. 2008 Feb, 62(2):263-273. PubMed PMID: 17487211.
21. Gagliardi A.C., Maranhao R.C., de Sousa H.P., Schaefer E.J., Santos R.D. Effects of margarines and butter consumption on lipid profiles, inflammation markers and lipid transfer to HDL particles in free-living subjects with the metabolic syndrome. Eur. J. Clin. Nutr. 2010 Oct, 64(10):1141-1149. PubMed PMID: 20648041.
22. Hansel B., Nicolle C., Lalanne F., Tondu F., Lassel T., Donazzolo Y., et al. Effect of low-fat, fermented milk enriched with plant sterols on serum lipid profile and oxidative stress in moderate hypercholesterolemia. Am. J. Clin. Nutr. 2007 Sep, 86(3):790-796. PubMed PMID: 17823447.
23. Hernandez-Mijares A., Banuls C., Jover A., Sola E., Bellod L., Martinez-Triguero M.L., et al. Low intestinal cholesterol absorption is associated with a reduced efficacy of phytosterol esters as hypolipemic agents in patients with metabolic syndrome. Clin. Nutr. 2011 Oct, 30(5):604-609. PubMed PMID: 21489663.
24. Hongu N., Kitts D.D., Zawistowski J., Dossett C.M., Kopec A., Pope B.T., et al. Pigmented rice bran and plant sterol combination reduces serum lipids in overweight and obese adults. J. Am. Coll. Nutr. 2014, 33(3):231-238. PubMed PMID: 24955613.
25. Plat J., Brufau G., Dallinga-Thie G.M., Dasselaar M., Mensink R.P. A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients. J. Nutr. 2009 Jun, 139(6):1143-1149. PubMed PMID: 19403719.
26. Sialvera T.E., Pounis G.D., Koutelidakis A.E., Richter D.J., Yfanti G., Kapsokefalou M., et al. Phytosterols supplementation decreases plasma small and dense LDL levels in metabolic syndrome patients on a westernized type diet. Nutrition, metabolism, and cardiovascular diseases. NMCD 2012 Oct, 22(10):843-848. PubMed PMID: 21316934.
27. Clifton P.M., Mano M., Duchateau G.S., van der Knaap H.C., Trautwein E.A. Dose-response effects of different plant sterol sources in fat spreads on serum lipids and C-reactive protein and on the kinetic behavior of serum plant sterols. Eur. J. Clin. Nutr. 2008 Aug, 62(8):968-977. PubMed PMID: 17538539.
28. Banuls C., Martinez-Triguero M.L., Lopez-Ruiz A., Morillas C., Lacomba R., Victor V.M., et al. Evaluation of cardiovascular risk and oxidative stress parameters in hypercholesterolemic subjects on a standard healthy diet including low-fat milk enriched with plant sterols. J. Nutr. Biochem. 2010 Sep, 21(9):881-886. PubMed PMID: 19889524.
29. Devaraj S., Jialal I., Vega-Lopez S. Plant sterol-fortified orange juice effectively lowers cholesterol levels in mildly hypercholesterolemic healthy individuals. Arterioscler. Thromb. Vasc. Biol. 2004 Mar, 24(3):e25-e28. PubMed PMID: 14764424.
30. Sola R., Valls R.M., Godas G., Perez-Busquets G., Ribalta J., Girona J., et al. Cocoa, hazelnuts, sterols and soluble fiber cream reduces lipids and inflammation biomarkers in hypertensive patients: a randomized controlled trial. PloS one 2012, 7(2):e31103. PubMed PMID: 22383996. Pubmed Central PMCID: 3287993.
31. Wan X., Wang W., Liu J., Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med. Res. Methodol. 2014 Dec 19, 14(1):135. PubMed PMID: 25524443.
32. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. trials 1986 Sep, 7(3):177-188. PubMed PMID: 3802833.
33. Hallikainen M., Lyyra-Laitinen T., Laitinen T., Agren J.J., Pihlajamaki J., Rauramaa R., et al. Endothelial function in hypercholesterolemic subjects: effects of plant stanol and sterol esters. Atherosclerosis 2006 Oct, 188(2):425-432. PubMed PMID: 16386259.
34. AbuMweis S.S., Vanstone C.A., Ebine N., Kassis A., Ausman L.M., Jones P.J., et al. Intake of a single morning dose of standard and novel plant sterol preparations for 4 weeks does not dramatically affect plasma lipid concentrations in humans. J. Nutr. 2006 Apr, 136(4):1012-1016. PubMed PMID: 16549466.
35. Houweling A.H., Vanstone C.A., Trautwein E.A., Duchateau G.S., Jones P.J. Baseline plasma plant sterol concentrations do not predict changes in serum lipids, C-reactive protein (CRP) and plasma plant sterols following intake of a plant sterol-enriched food. Eur. J. Clin. Nutr. 2009 Apr, 63(4):543-551. PubMed PMID: 18073779.
36. Madsen M.B., Jensen A.M., Schmidt E.B. The effect of a combination of plant sterol-enriched foods in mildly hypercholesterolemic subjects. Clin. Nutr. 2007 Dec, 26(6):792-798. PubMed PMID: 17719702.
37. Theuwissen E., Plat J., Mensink R.P. Consumption of oat beta-glucan with or without plant stanols did not influence inflammatory markers in hypercholesterolemic subjects. Mol. Nutr. food Res. 2009 Mar, 53(3):370-376. PubMed PMID: 18979504.
38. Reiner Z., Catapano A.L., De Backer G., Graham I., et al. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur. Heart J. 2011 Jul, 32(14):1769-1818. European Association for Cardiovascular P, Rehabilitation, PubMed PMID: 21712404.
39. Ference B.A., Yoo W., Alesh I., Mahajan N., Mirowska K.K., Mewada A., et al. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J. Am. Coll. Cardiol. 2012 Dec 25, 60(25):2631-2639. PubMed PMID: 23083789.
40. Stroes E.S., Thompson P.D., Corsini A., Vladutiu G.D., Raal F.J., Ray K.K., et al. Statin-associated muscle symptoms: impact on statin therapy-European atherosclerosis society consensus panel statement on assessment, aetiology and management. Eur. Heart J. 2015 May 1, 36(17):1012-1022. PubMed PMID: 25694464. Pubmed Central PMCID: 4416140.
41. Kinlay S. Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis. J. Am. Coll. Cardiol. 2007 May 22, 49(20):2003-2009. PubMed PMID: 17512355.
42. Nissen S.E., Tuzcu E.M., Schoenhagen P., Crowe T., Sasiela W.J., Tsai J., et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N. Engl. J. Med. 2005 Jan 6, 352(1):29-38. PubMed PMID: 15635110.
43. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., et al. C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med. 2005 Jan 6, 352(1):20-28. PubMed PMID: 15635109.
44. Ridker P.M., Rifai N., Pfeffer M.A., Sacks F.M., Moye L.A., Goldman S., et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events (CARE) investigators. Circulation 1998 Sep 1, 98(9):839-844. PubMed PMID: 9738637.
45. Bohula E.A., Giugliano R.P., Cannon C.P., Zhou J., Murphy S.A., White J.A., et al. Achievement of Dual low-density lipoprotein cholesterol and high-sensitivity c-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with Better outcomes in IMPROVE-IT. Circulation 2015 Sep 29, 132(13):1224-1233. PubMed PMID: 26330412.
46. Raal F.J., Stein E.A., Dufour R., Turner T., Civeira F., Burgess L., et al. PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial. Lancet 2015 Jan 24, 385(9965):331-340. PubMed PMID: 25282519.
47. Selvin E., Paynter N.P., Erlinger T.P. The effect of weight loss on C-reactive protein: a systematic review. Archives Intern. Med. 2007 Jan 8, 167(1):31-39. PubMed PMID: 17210875.
48. Belalcazar L.M., Reboussin D.M., Haffner S.M., Hoogeveen R.C., Kriska A.M., Schwenke D.C., et al. A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care 2010 Nov, 33(11):2297-2303. PubMed PMID: 20682679. Pubmed Central PMCID: 2963483.
49. Nicklas J.M., Sacks F.M., Smith S.R., LeBoff M.S., Rood J.C., Bray G.A., et al. Effect of dietary composition of weight loss diets on high-sensitivity c-reactive protein: the randomized POUNDS LOST trial. Obes. (Silver Spring) 2013 Apr, 21(4):681-689. PubMed PMID: 23712970. Pubmed Central PMCID: 3671388.